nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addendum needed on COVID-19 travel study
|
Altenberg, Lee |
|
|
21 |
11 |
p. 1494-1495 |
artikel |
2 |
Addendum needed on COVID-19 travel study – Authors' reply
|
Kiang, Mathew V |
|
|
21 |
11 |
p. 1495-1496 |
artikel |
3 |
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
|
Chang, Kwok-Chiu |
|
|
21 |
11 |
p. 1491-1492 |
artikel |
4 |
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
|
Khouri, Charles |
|
|
21 |
11 |
p. 1490-1491 |
artikel |
5 |
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination – Authors' reply
|
Wong, Ian Chi Kei |
|
|
21 |
11 |
p. 1492-1493 |
artikel |
6 |
Antibiotics in nursing homes: a tailored intervention
|
Bodilsen, Jacob |
|
|
21 |
11 |
p. 1476-1477 |
artikel |
7 |
Antibody responses to filovirus infections in humans: protective or not?
|
Ilinykh, Philipp A |
|
|
21 |
11 |
p. e348-e355 |
artikel |
8 |
Assessing the effect of BCG revaccination on long-term mortality
|
Netea, Mihai G |
|
|
21 |
11 |
p. 1481-1483 |
artikel |
9 |
Biodefence research: what to fund now?
|
Simon, Fabrice |
|
|
21 |
11 |
p. 1487-1488 |
artikel |
10 |
Bold measures to accelerate malaria elimination
|
Price, Ric N |
|
|
21 |
11 |
p. 1480-1481 |
artikel |
11 |
Correction to Lancet Infect Dis 2021; 21: 1507–17
|
|
|
|
21 |
11 |
p. e341 |
artikel |
12 |
Correction to Lancet Infect Dis 2020; published online Aug 5. https://doi.org/10.1016/S1473-3099(21)00191-2
|
|
|
|
21 |
11 |
p. e341 |
artikel |
13 |
Crisis as a political ally: the unexpected power of AIDS
|
Geraldes, Flávia Oliveira |
|
|
21 |
11 |
p. 1506 |
artikel |
14 |
Effectiveness of a tailored intervention to reduce antibiotics for urinary tract infections in nursing home residents: a cluster, randomised controlled trial
|
Arnold, Sif Helene |
|
|
21 |
11 |
p. 1549-1556 |
artikel |
15 |
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study
|
Hyams, Catherine |
|
|
21 |
11 |
p. 1539-1548 |
artikel |
16 |
Hospitalisation among vaccine breakthrough COVID-19 infections
|
Juthani, Prerak V |
|
|
21 |
11 |
p. 1485-1486 |
artikel |
17 |
Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort
|
Sipilä, Pyry N |
|
|
21 |
11 |
p. 1557-1567 |
artikel |
18 |
IDWeek 2021
|
Kazi, Farooq |
|
|
21 |
11 |
p. 1497 |
artikel |
19 |
Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas
|
Sah, Pratha |
|
|
21 |
11 |
p. 1493-1494 |
artikel |
20 |
Increasing COVID-19 vaccine uptake in Black Americans
|
Burki, Talha |
|
|
21 |
11 |
p. 1500-1501 |
artikel |
21 |
India's COVID-19 vaccination drive: key challenges and resolutions
|
Choudhary, Om Prakash |
|
|
21 |
11 |
p. 1483-1484 |
artikel |
22 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
21 |
11 |
p. 1501 |
artikel |
23 |
Jennifer Keiser—Improving treatment of helminth infections
|
Kirby, Tony |
|
|
21 |
11 |
p. 1504 |
artikel |
24 |
Karamojong people embrace malaria chemoprevention
|
Nakkazi, Esther |
|
|
21 |
11 |
p. 1499 |
artikel |
25 |
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
|
McLean, Alistair R D |
|
|
21 |
11 |
p. 1579-1589 |
artikel |
26 |
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
|
Patone, Martina |
|
|
21 |
11 |
p. 1518-1528 |
artikel |
27 |
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities
|
Dal-Ré, Rafael |
|
|
21 |
11 |
p. e342-e347 |
artikel |
28 |
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
|
Drolet, Mélanie |
|
|
21 |
11 |
p. 1598-1610 |
artikel |
29 |
Periocular tinea caused by zoonotic Trichophyton benhamiae
|
Sips, Gregorius J |
|
|
21 |
11 |
p. 1612 |
artikel |
30 |
Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis
|
Arora, Navneet |
|
|
21 |
11 |
p. 1611 |
artikel |
31 |
Research in brief
|
Devi, Sharmila |
|
|
21 |
11 |
p. 1502 |
artikel |
32 |
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
|
Bager, Peter |
|
|
21 |
11 |
p. 1507-1517 |
artikel |
33 |
SARS-CoV-2 variants and considerations of inferring causality on disease severity
|
Cevik, Muge |
|
|
21 |
11 |
p. 1472-1474 |
artikel |
34 |
Shaik Khader Noordeen
|
Bagcchi, Sanjeet |
|
|
21 |
11 |
p. 1503 |
artikel |
35 |
Should infectious diseases be targeted to prevent dementias?
|
Bu, Xian-Le |
|
|
21 |
11 |
p. 1477-1478 |
artikel |
36 |
Single-dose SARS-CoV-2 vaccination efficacy in the elderly
|
Prendecki, Maria |
|
|
21 |
11 |
p. 1474-1475 |
artikel |
37 |
Sizing the reservoirs of malaria transmission: the contribution of school-aged children
|
Mayor, Alfredo |
|
|
21 |
11 |
p. 1478-1480 |
artikel |
38 |
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study
|
Andolina, Chiara |
|
|
21 |
11 |
p. 1568-1578 |
artikel |
39 |
Spinal epidural abscess caused by Aspergillus spp masquerading as spinal tuberculosis in a person with HIV
|
Rule, Roxanne |
|
|
21 |
11 |
p. e356-e362 |
artikel |
40 |
The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi
|
Glynn, Judith R |
|
|
21 |
11 |
p. 1590-1597 |
artikel |
41 |
Transaminases and serum albumin as early predictors of severe dengue
|
Lazarus, Gilbert |
|
|
21 |
11 |
p. 1488-1489 |
artikel |
42 |
Transaminases and serum albumin as early predictors of severe dengue – Authors' reply
|
Sangkaew, Sorawat |
|
|
21 |
11 |
p. 1489-1490 |
artikel |
43 |
Unmet need for COVID-19 therapies in community settings
|
The Lancet Infectious Diseases, |
|
|
21 |
11 |
p. 1471 |
artikel |
44 |
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
|
Shrotri, Madhumita |
|
|
21 |
11 |
p. 1529-1538 |
artikel |
45 |
Validating BSAC guidance for the management of children with fever and non-blanching rash
|
Waterfield, Thomas |
|
|
21 |
11 |
p. 1487 |
artikel |
46 |
Voices from the abyss
|
De Ambrogi, Marco |
|
|
21 |
11 |
p. 1505 |
artikel |
47 |
WHO manual on neglected tropical diseases
|
Bagcchi, Sanjeet |
|
|
21 |
11 |
p. 1498 |
artikel |